VANGUARD BD INDEX FDS - INTERMED TERM (BIV)

CUSIP: 921937819

Q1 2022 13F Holders as of 31 Mar 2022

Security identity
Holder snapshot
Share change
-674,590
Reported price per share
$81.90
Number of holders
709
Value change
-$60,691,479
Number of buys
340
Number of sells
334

Security key

921937819

Report period

Q1 2022

Institutions

709

Top holders

10

Ownership snapshot

Top reported holders of BIV - VANGUARD BD INDEX FDS - INTERMED TERM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
13D/G signal
Evidence rows
0
Latest as of
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
709
Shares
90,826,478
Rows available
709
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 holders
718
Q1 2022 holders
709
Holder diff
-9
Investor Q4 2021 Shares Q1 2022 Shares Share Diff Share Chg % Q4 2021 value Q1 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .